China Resources Boya Bio-pharmaceutical Group Co.,Ltd Stock
Equities
300294
CNE100001FF1
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33.4 CNY | -0.98% | -3.24% | -0.83% |
Sales 2024 * | 1.86B 257M | Sales 2025 * | 2.04B 282M | Capitalization | 17.01B 2.35B |
---|---|---|---|---|---|
Net income 2024 * | 557M 77.01M | Net income 2025 * | 601M 83.09M | EV / Sales 2024 * | 9.13 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 8.35 x |
P/E ratio 2024 * |
30.5
x | P/E ratio 2025 * |
28.3
x | Employees | 1,444 |
Yield 2024 * |
0.92% | Yield 2025 * |
1.04% | Free-Float | 16.25% |
1 day | -1.32% | ||
1 week | -2.29% | ||
Current month | +7.22% | ||
1 month | +6.61% | ||
3 months | +20.64% | ||
6 months | +1.84% | ||
Current year | +0.15% |
Managers | Title | Age | Since |
---|---|---|---|
Xiao Ming Liang
CEO | Chief Executive Officer | 57 | 93-11-05 |
Hua Cheng Liang
DFI | Director of Finance/CFO | 42 | 21-08-31 |
Zhen Rao
BRD | Director/Board Member | 56 | 93-11-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Dong Zhang
BRD | Director/Board Member | 61 | 21-02-02 |
Xiao Ming Liang
CEO | Chief Executive Officer | 57 | 93-11-05 |
Zhen Rao
BRD | Director/Board Member | 56 | 93-11-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 33.4 | -0.98% | 3 695 751 |
24-05-20 | 33.73 | -1.32% | 3,796,745 |
24-05-17 | 34.18 | -0.06% | 4,714,178 |
24-05-16 | 34.2 | -0.64% | 7,481,835 |
24-05-15 | 34.42 | -0.15% | 2,367,850 |
End-of-day quote Shenzhen S.E., May 19, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.15% | 2.35B | |
-3.15% | 89.69B | |
+3.95% | 41.34B | |
-12.87% | 33.72B | |
+61.79% | 26.11B | |
-20.64% | 14.63B | |
-9.22% | 12.84B | |
-12.34% | 11.66B | |
-43.05% | 11.52B | |
+4.19% | 8.92B |
- Stock Market
- Equities
- 300294 Stock